Pharma, healthcare sector attract investment despite volume dip in Q3 2023: Report
The quarter saw 26 deals totalling $2.7 billion, with a 32 per cent decline in deal volumes compared to Q3 2022
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Deals
Glenmark to divest majority stake in Glenmark Life Sciences to Nirma
Nirma will acquire 75 per cent stake in Glenmark Life Sciences at a price of Rs 615/- per share
Novo Nordisk to acquire Inversago Pharma for up to $1.075 bn
The acquisition of Inversago includes the company’s lead development asset INV-202, an oral CB1 inverse agonist
Sigachi Industries forays into API business, acquires majority stake in Trimax Bio Sciences
The API unit is approved by USFDA for advanced and critical intermediates
Novartis acquires DTx Pharma
Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two…
Glenmark, Cediprof partner to alleviate US amphetamine shortage
Announce exclusive US distribution pact, distribution expected to start during the second half of 2023
Redx, Jounce announce recommended business combination
Combined group will have a strong clinical pipeline and proven expertise in the discovery and development of highly selective…
Control Print, V Shapes announce JV for sustainable packaging solutions in India
This JV will produce recyclable/biodegradable single-use packets for a wide range of products including liquids, viscous and…
Sun Pharma acquires Disperzyme and Phlogam brands to strengthen its anti-inflammatory portfolio
Disperzyme and Phlogam are fixed-dose combinations of proteolytic enzymes and bioflavonoid viz Tryspin, Bromelain and Rutoside…
Prochem joins hands with Tapasya
The new business entity, Prochem Tapasya, will add value to create a one-stop solution for pharma and allied industries